[Effects of BIO-1211 on eosinophil chemotaxis, recruitment and mediator release]. 2003

Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
Zhejiang Respiratory Drugs Research Laboratory of State Food and Drug Administration of China, College of Medicine, Zhejiang University, Hangzhou 310031, China.

To study the effects of very late antigen(VLA) antagonist BIO-1211 on eosinophil chemotaxis, recruitment and mediator release. Eosinophil chemotaxis was induced by platelet activating factor(PAF) in vitro and eosinophil recruitment and release were determined in vivo. VLA antagonist BIO-1211 inhibited eosinophil chemotaxis induced by PAF. The inhibitory rates at 4x10(-11), 4x10(-10), 4x10(-9) mol x L(-1) were 24.9%, 29.9%, and 31.3%, respectively. Pretreatment by BIO-1211 1, 3 and 10 mg x kg(-1) intraperitoneally inhibited the recruitment of eosinophils in PAF in the rat induced by Sephadex in a dose dependent manner. Inhibitory rates were 60.3%, 68.9%, and 72.9%(P<0.05), respectively. BIO-1211 did not inhibit eosinophil peroxidase(EPO) release from eosinophils. BIO-1211 inhibits eosinophil chemotaxis and recruitment, alleviates local inflammation, and may represent a new type of drug for allergic diseases.

UI MeSH Term Description Entries
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010544 Peroxidases Ovoperoxidase
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
May 2000, IDrugs : the investigational drugs journal,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
June 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
July 1995, The European respiratory journal,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
January 1981, The Journal of clinical investigation,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
February 1998, Scandinavian journal of immunology,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
July 2008, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
January 1978, International archives of allergy and applied immunology,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
November 1981, The American journal of pathology,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
January 1981, Kroc Foundation series,
Xiao-yan Zhao, and Ji-qiang Chen, and Qiang-min Xie, and Hui-fang Tang, and Ru-lain Bian
January 1991, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!